Results 101 to 110 of about 28,723 (210)

Apixaban versus enoxaparin in patients with total knee arthroplasty

open access: yes, 2011
SummaryIt was the objective of this study to systematically compare the effects of apixaban versus enoxaparin in patients following total knee arthroplasty (TKA).
Liucheng Wu   +4 more
core   +1 more source

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study

open access: yesJournal of Research in Pharmacy Practice
Objective: Anticoagulation therapy, including enoxaparin, is crucial for preventing blood clots in patients at risk for thromboembolic events. However, due to enoxaparin’s enhanced renal elimination, proper prophylactic dosing may be challenging.
Zahra Sahraei   +2 more
doaj   +1 more source

Development of enoxaparin sodium polymeric microparticles for colon-specific delivery

open access: yes, 2015
International audienceBackground and aimsRecent studies have shown that low molecular weight heparins are effective in the treatment of inflammatory bowel disease.
Ioan Tomuţa   +13 more
core   +1 more source

Effect of enoxaparin on macrophage infiltration into the inflamed colon.

open access: yes, 2015
(A) Representative immunostaining of F4/80-positive macrophages in in the distal colon from healthy and colitic mice treated with and without enoxaparin. (B) Quantification of macrophages (F4/80+ cells) in the colons.
Sarron Randall-Demllo (776243)   +7 more
core   +1 more source

Bioequivalence of a biosimilar enoxaparin sodium to Clexane® after single 100 mg subcutaneous dose: results of a randomized, double-blind, crossover study in healthy volunteers

open access: yes, 2018
Javier Martínez González, Mayte Monreal, Ignacio Ayani Almagia, Jordi Llaudó Garín, Lourdes Ochoa Díaz de Monasterioguren, Ibón Gutierro Adúriz R&D Department, Laboratorios Farmacéuticos Rovi S.
Ayani Almagia I   +5 more
core  

NMR assignments of enoxaparin disaccharide.

open access: yes, 2015
Atoms in the glucosamine unit are denoted by the prime superscript.Cq (COO-) 169.1 ppm, C6 (Ido) 144.79 ppm.NMR assignments of enoxaparin disaccharide.
Madhur D. Shastri (698427)   +6 more
core   +1 more source

Use of enoxaparin in end-stage renal disease

open access: yes, 2013
Enoxaparin has become the treatment of choice for various thromboembolic diseases. In most patients with end-stage renal disease (ESRD), prophylactic dosage of enoxaparin does not appear to be associated with an increased bleeding risk and can be used ...
LAI, SILVIA, Bettina Coppola
core   +1 more source

Enoxaparin : physicochemical investigations into the effects of freezing and heating

open access: yes, 2008
Introduction Low-molecular-weight heparins (LMWHs) are modified heparin fractions with a molecular weight range of 2 OOO to 8 OOO Da prepared by chemical or enzymatic depolymerisation of unfractionated heparin (UFH).
Patel, Rahul Prabhudas (15940718)
core   +1 more source

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure

open access: yesJournal of Health Economics and Outcomes Research
# Background Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are risk factors for venous thromboembolism (VTE). Enoxaparin and unfractionated heparin (UFH) help prevent hospital-associated VTE, but few studies have compared them in ...
Alpesh N. Amin   +4 more
doaj   +1 more source

Dose individualisation of enoxaparin

open access: yes, 2009
The global aims of this thesis were: to evaluate if an individualised dose strategy for enoxaparin, based on lean body weight and renal function, resulted in a reduction in the prevalence of bleeding and bruising events when compared to conventional ...
Michael Barras
core  

Home - About - Disclaimer - Privacy